Brad Cole: Genomic Science and Patient-Directed Cancer Treatment Decisions - 2012 T3 Talks

423 views · Published 22 March 2013 · 34:19 · Indexed 20 October 2026

Channel: Biola University · 2013 · Education

Watch on YouTube

Full Title: Empowering Patient-Directed Cancer Treatment Decisions through Genomic-Based Clinical Laboratory Services

T3 Talks at Biola University: Intelligent talks by accomplished alumni from an array of backgrounds and professions. Interact with six high-profile Christian communicators: a filmmaker, a published authority on Victorian literature, a medical entrepreneur, a sought-after fashion designer... and more.

Brad Cole ('78), is the Chief Operating Officer of Genomic Health, Inc., committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. Brad led their initial public offering in 2005. Brad has served as COO, CFO & Executive VP. In prior roles in other companies, Brad was a designer and developer of cardiovascular medical products. Brad holds a Bachelor of Science in Business from Biola University and an MBA from San Jose State University. 2012 Biola Alumni Award recipient.

More from this channel